Skip to Main Content

2,051

Views

1

CrossRef citations to date

0

Altmetric

Original Article

Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis

Efstathios Kastritisa Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, GreeceView further author information

,

Arpit Misrab Cytel, Rotterdam, NetherlandsView further author information

,

Laura Gurskyteb Cytel, Rotterdam, NetherlandsView further author information

,

Florint Kroib Cytel, Rotterdam, NetherlandsView further author information

,

Andre Verhoekb Cytel, Rotterdam, NetherlandsView further author information

,

Jessica Vermeulenc Janssen Research & Development, LLC, Leiden, NetherlandsView further author information

,

Eric Ammannd Janssen Global Services, LLC, Raritan, NJ, USACorrespondence[email protected]
View further author information

,

Annette Lamd Janssen Global Services, LLC, Raritan, NJ, USAView further author information

,

Sarah Coted Janssen Global Services, LLC, Raritan, NJ, USAView further author information

&

Ashutosh D. Wechalekare National Amyloidosis Centre, University College London, London, UKView further author information